(BPT) – Do you live with persistent, moderate-to-severe asthma, COPD, allergies, eczema or hives? Inflammation is often a major factor in the severity of your symptoms. It could also be a factor if ...

Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel, shares the latest clinical discoveries from the BOREAS trial on type 2 inflammation in patients with chronic ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Asthma and cardiovascular diseases (CVDs) are intricately linked, because of their widespread prevalence ...

Panelists discuss how identifying type 2 inflammation in patients influences treatment decisions by steering clinicians toward targeted therapies, such as biologics or other immunomodulators, that ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. This analysis used BOREAS and NOTUS trial data.

24 abstracts, including 1 oral presentation and 4 late-breaking posters on Dupixent, to showcase new clinical and real-world analyses in chronic obstructive pulmonary disease (COPD) and asthma COPD ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In those with and those without emphysema, patients ...

At this year's EASD Meeting, the Camillo Golgi lecture was given by Professor Antonio Ceriello, Chair of Internal Medicine, University of Udine, Italy. Professor Ceriello has systematically studied ...